Form EFFECT Edesa Biotech, Inc.
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | July 13, 2026 4:05 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- From China Trials to Abu Dhabi: FREELANDER 8 Builds Momentum for Global Brand Launch
- Bitcoin Price Prediction: BTC Eyes New Highs as Apeing’s Next Big Crypto Presale Targets 2,400% ROI After Raising Over $68K
- Best Crypto Presale: $0.0589 DigiTap Targets a $0.14 Listing Price With 350M+ TAP Already Sold
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share